MedPath

A comparative study of lashuna taila and narayana taila uttarbasti in the treatment of female infertility

Phase 2
Not yet recruiting
Conditions
Chronic salpingitis and oophoritis. Ayurveda Condition: VANDHYA,
Registration Number
CTRI/2025/06/089222
Lead Sponsor
State ayurvedic College and Hospital Lucknow
Brief Summary

this is a randomised comparative clinical study phase 2 parallel group trial . Comparing the efficacy of Lashuna taila uttarbasti and Narayana taila uttarbasti in case of stri bandhyattava for 3 months in 30 patients . The patient fulfilling the cclinical criteria for diagnosis of stri bandhyattava will be randomly selected from OPD / IPD of State Ayurvedic College and Hospital Lucknow and referred cases from other hospitals . a careful history , physical examination and necessary investigations will be performed . further patients divided into two groups , Group A- patient will be treated with Lashuna taila uttarbasti in the dose 3-5 ml through transvaginal route after cessation of menses for 3 alternative days for 3 consecutive cycles in Group B - patient will be treated with Narayana taila uttarbasti in the dose of 3- 5 ml through transvaginal route after cessation of menses for 3 alternative days for 3 concsecative cycles . Follow up period after 30 days with trial drug and last follow up after 30 days of completion of trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • 1.Married women with Age between 21 to 40 years.
  • 2.Patient of primary and secondary infertility 3.Clinically diagnosed Patients of unilateral or bilateral tubal blockage.
Exclusion Criteria
  • 1.Patient with active and chronic pelvic infections.
  • 2.Patient of any Genital organ diseases like- Uterine fibroid.
  • Genital Prolapse Endometriosis, Adenomyosis etc.
  • 3.Patient with history of hypdrosalpinx.
  • 4.Women of age less than 21 and above than 40.
  • 5.Other systemic disorders like hypertension, diabetes, tuberculosis.
  • 7.Patient having organic pathology of uterus and adnexal like cervical carcinoma, Cervical Intraepithelial Neoplasia (CIN).
  • And any malignant growth.
  • 8.HIV, VDRL, HBsAg positive patient.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to evaluate the efficacy of lashuna taila and narayana taila uttarbasti in management of tubal blockageafter 30 days | after 30 days | after 30 days | after 30 days of trial
Improvement in tubal patencyafter 30 days | after 30 days | after 30 days | after 30 days of trial
Secondary Outcome Measures
NameTimeMethod
Conception / pregnancy rateReduction in associated symptoms of bandhayyatava

Trial Locations

Locations (1)

State Ayurvedic College and Hospital Tulsidas marg Turiyaganj Lucknow

🇮🇳

Lucknow, UTTAR PRADESH, India

State Ayurvedic College and Hospital Tulsidas marg Turiyaganj Lucknow
🇮🇳Lucknow, UTTAR PRADESH, India
Dr Gulafshan
Principal investigator
7905628653
khangulafshan80@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.